期刊文献+

271株肠球菌属细菌的分布和耐药性分析 被引量:10

Distribution and antibiotic resistance of 271 Enterococcus isolates
下载PDF
导出
摘要 目的了解内蒙古鄂尔多斯市中心医院临床分离的肠球菌属细菌的分布情况及对各类抗菌药物的耐药性。方法使用VITEK2 compact全自动细菌检测分析系统对2010年1月至2013年6月从临床标本中分离的271株肠球菌属细菌进行菌种鉴定和药敏试验,并用WHONET5.6软件对结果进行统计分析。结果 271株肠球菌属细菌中,屎肠球菌137株(50.6%),粪肠球菌80株(29.5%),其他肠球菌54株(19.9%)。肠球菌属细菌主要分离自尿液69株(25.5%)、脓液40株(14.8%)、伤口等分泌物34株(12.5%)。粪肠球菌对万古霉素和利奈唑胺的耐药率分别为1.3%和1.5%;未检出呋喃妥因耐药株;对青霉素和氨苄西林的耐药率较低,分别为11.8%和2.6%;对高浓度庆大霉素和高浓度链霉素的耐药率分别为31.0%和22.9%。屎肠球菌的耐药率明显高于粪肠球菌,对万古霉素的耐药率为4.4%,未检出利奈唑胺耐药株,对呋喃妥因的耐药率为19.1%;对高浓度庆大霉素和高浓度链霉素的耐药率分别为44.8%和26.4%;但对四环素和奎奴普丁-达福普汀的耐药率低于粪肠球菌,分别为58.3%和0。结论屎肠球菌对抗菌药物的耐药率较粪肠球菌高;并已出现对万古霉素耐药株;其耐药性存在地区和菌种间差异,临床治疗应根据细菌药敏结果合理选用抗菌药物。 Objective To investigate the distribution and antimicrobial resistance in Enterococcus species isolated from Ordos Central Hospital. Methods The Enterococcus strains were isolated from clinical specimens from January 2010 to June 2013. The identification and antimicrobial susceptibility testing were completed on VITEK 2 Compact. WHONET 5.6 software was used to analyze the data. Results A total of 271 strains of Enterococcus were collected, including E. faecium (50.6%, 137/271), E. faecalis (29.5 %, 80/271), and other Enterococcus (19.9%, 54/271). The Enterococcus isolates were mainly from urine (25.5%, 69/271), pus (14. 8%, 40/271) and wound secretion (12. 5%, 34/271). The E. faecalis strains were highly susceptible to vancomycin and linezolid. Only 1. 3% and 1. 5% of the strains were resistant to vancomycin and linezolid, respectively. No strains of E, faecalis were resistant to nitrofurantoin. The percentage of E. faecalis resistant to penicillin and ampicillin was 11. 8% and 2. 6%, respectively. About 31. 0% and 22. 9% of E. faecalis strains were resistant to gentamicin (high level) and streptomycin (high level), respectively. The E. faecium strains were more resistant to most antibiotics tested than E. faecalis. The drug-resistance rate of E. faecium strains to vancomycin was 4.4%. But no strains were found resistant to linezolid. Only 19.1% of these strains were resistant to nitrofurantoin. Also 44.8% and 26.4% of E. faecium isolates were resistant to gentamicin (high level) and streptomycin (high level), respectively. However, E. faeciurn was less resistant to tetracycline and quinupristin-dalfopristin than E. faecalis. The resistance rate was 58. 3% and 0, respectively. Conclusions The E. faeciurn strains are more resistant to most drugs tested than E. faecalis. Some strains are resistant to vancomycin. The resistance of Enterococcus varies widely with region and species. Antimicrobial therapy for such enterococcal infections should be based on the results of antimicrobial susceptibility testing.
出处 《中国感染与化疗杂志》 CAS 北大核心 2014年第4期323-326,共4页 Chinese Journal of Infection and Chemotherapy
基金 内蒙古自然科学基金(2013MS1116)
关键词 肠球菌属 抗生素 耐药性 Enterococcus antibiotic resistance
  • 相关文献

参考文献12

  • 1胡付品,朱德妹,汪复,蒋晓飞,杨青,徐英春,张小江,孙自镛,陈中举,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,单斌,杜艳,徐元宏,沈继录,张泓,孔菁,卓超,苏丹虹,张朝霞,季萍,胡云建,艾效曼,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2012,12(5):321-329. 被引量:526
  • 2Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Twenty second Information Supplement[S]. 2012,M100-S22.
  • 3汪复,朱德妹,胡付品,蒋晓飞,胡志东,李全,孙自镛,陈中举,徐英春,张小江,王传清,王爱敏,倪语星,孙景勇,褚云卓,俞云松,林洁,徐元宏,沈继录,苏丹虹,卓超,魏莲花,吴玲,张朝霞,季萍,张泓,孔菁,胡云建,艾效曼,单斌,杜艳.2012年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):321-330. 被引量:465
  • 4杨青,俞云松,倪语星,孙景勇,徐英春,张小江,孙自镛,陈中举,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,卓超,苏丹虹,胡云建,艾效曼,黄文祥,贾蓓,张朝霞,季萍,张泓,孔菁,魏莲花,吴玲,徐元宏,沈继录,单斌,杜艳.2010年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2012,12(2):92-97. 被引量:61
  • 5Sood S, Malhotra M, Das BK, et al. Enterococcal infections antimicrobial resistance[J]. Indian J Med Res, 2008,128 (2) 111-121.
  • 6瞿婷婷,俞云松,孙自镛,陈中举,徐英春,张小江,汪复,朱德妹,胡付品,卓超,苏丹虹,张泓,孔菁,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,单斌,杜艳,胡云建,艾效曼,徐元宏,沈继录,黄文祥,贾蓓,魏莲花,吴玲.2011年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2013,13(5):337-341. 被引量:32
  • 7姚杰,徐元宏.耐万古霉素肠球菌的耐药机制及耐药基因调控的研究进展[J].国外医药(抗生素分册),2010,31(1):24-28. 被引量:16
  • 8朱德妹,汪复,胡付品,倪语星,孙景勇,王传清,王爱敏,俞云松,杨青,徐元宏,沈继录,孙自镛,陈中举,徐英春,张小江,单斌,杜艳,卓超,苏丹虹,胡云建,艾效曼,张朝霞,季萍,贾蓓,黄文祥,张泓,孔菁,魏莲花,吴玲.2010年中国CHINET尿液标本中细菌的分布和耐药性监测[J].中国感染与化疗杂志,2012,12(4):241-250. 被引量:67
  • 9Wang JL, Hsueh PR. Theropeutic options for infections due to vancomycin resistant enterococci [ J ]. Expert Opin Pharmacother, 2009, 10(5) : 785-796.
  • 10Barnaud G, Bingen E. Genotypic characterization of endemic VanA Enterococcus faecium strains isolated in a paediatrie hospital[J]. J Med Microbiol, 2000,49 (9) :793-799.

二级参考文献93

  • 1杨青,俞云松,倪语星,孙景勇,徐英春,孙宏莉,孙自镛,简翠,汪复,朱德妹,胡付品,蒋晓飞,王传清,王爱敏,卓超,苏丹虹,胡云建,艾效曼,黄文祥,贾蓓,张朝霞,季萍,张泓,李万华,魏莲花,吴玲,徐元宏,沈继录,单斌,杜艳.2009年中国CHINET肠球菌属细菌耐药性监测[J].中国感染与化疗杂志,2010,10(6):421-425. 被引量:61
  • 2朱德妹,汪复,张婴元.2005年上海地区细菌耐药性监测[J].中国感染与化疗杂志,2006,6(6):371-376. 被引量:82
  • 3Reynolds PE, Courvalin P. Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine [J]. Antimicrob Agents Chemother, 2005, 49(1):21.
  • 4Arthur M, Molinas C, Depardieu F, et al. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 [J]. J Bacteriol,1993,175(1):117.
  • 5Bugg TD, Wright GD, Dutka-Malen S, et al. Molecular basis for vancomycin resistance in Enterococcus faecium BM4147:biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA [J]. Biochemistry, 1991, 30(43): 10408.
  • 6Reynolds PE, Depardieu F, Dutka-Malen S, et al. Glycopeptide resistance mediated by enterococcal transposon Tn1546 requires production of VanX for hydrolysis of D-alanyl-D-alanine [J]. Mol Microbiol,1994, 13(6):1065.
  • 7Wu Z, Wright GD, Walsh CT. Overexpression, purification and characterization of VanX, a D,D-dipeptidase which is essential for vancomycin resistance in Enterococcus faecium BM4147 [J]. Biochemistry, 1995, 34(8):2455.
  • 8Arthur M, Molinas C, Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147 [J]. J Bacteriol, 1992, 174(8):2582.
  • 9Evers S, Courvalin P. Regulation of VanB-type vancomycin resistance gene expression by the VanS(B)- VanR(B) two-component regulatory system in Enterococcus faecalis V583 [J]. J Bacteriol, 1996, 178(5):1302.
  • 10Billot-Klein D, Gutmann L, of peptidoglycan precursors Sable S, et al. Modification is a common feature of the low-level vancomycin-resistant VanB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides,and Enterococcus gallinature [J]. J Bacteriol, 1994, 176(8):2398.

共引文献1079

同被引文献83

  • 1董叶丽,陈坤.外科术后中心静脉导管相关性感染危险因素的调查分析[J].中华护理杂志,2007,42(6):565-567. 被引量:60
  • 2Gil RG, Gomez MPR, Arias AG, et al. Nosocoial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital[J3. Diagn Microbio Infect Dis, 2009, 65(2): 175-9.
  • 3Souli M, Sakka V, Galani I, et al. Colonisation with vancomycin and linezolid-resistant Enterococcus faeciumin a university Lin- ezolidresistant Hospital molecular epidemiology and risk factor a- nalysis[J]. Int J Antimicrob Agents, 2009, 33(2) : 137-42.
  • 4Bader MS, Hawboldt J, Brooks A. Management of complicated u- rinary tract infections in the era of antimicrobial resistance[J]. Postgrand Med, 2010, 122(6): 7-15.
  • 5Rybak JM, Barber KE, Rybak MJ. Current and prospective treat ments for multidrugresistant grampositive infections[J]. Expert ()pin Pharmacother, 2013, 14(14): 1919-32.
  • 6Huckabee CM, Huskins WC, Murray PR. Predicting clearance of colonization with van-comycin-resistant Enterococci and Methi- cillimresistant Staphylococcus aureus by use of weekly surveil- lance Cultures[J]. J ClinMicrobiol, 2009, 47(1): 1229-30.
  • 7Boehr DD, Daigle DM, Wright GD. Domain-domain interactions in the aminoglycoside antibiotic resistance enzyme AAC (6)-APH (2)[J]. Biochemistry, :)004, 43(30): 9846-55.
  • 8Draker KA, Wright GD. Molecular mechanism of the enterococ- cal aminoglycoside 6 N acetyl transferase: role of GNAT con- served residues in the chemistry of antibiotic inactivation [J]. Bi- ochemistry, 2004, 43(2): 446-54.
  • 9Douthwaite S, Hansen LH, Mauvals P. Macrolide ketolide inhi- bition of MLS-resistant ribosomes is improved by alternative drug interaction with domain II of 23S rRNA[J]. Mol Microbiol, 2000, 36(1): 183.
  • 10Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Twenty-forth informational supplement, 2014. M100-S24.

引证文献10

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部